Core Lab Q2 FY26 EPS drops 40.9% year-over-year to $0.13; revenue falls 4.3% to $124.6 million
CLB•Second-quarter results
Core Laboratories posted Q2 2026 revenue of $124.6 million, up 2% sequentially and down 4% year-over-year.
GAAP operating income rose to $9.2 million from $1.89 million sequentially; GAAP EPS was $0.13.
Free cash flow was $3.1 million; the company repurchased 214,712 shares for $2.7 million.
Segment performance and outlook
Reservoir Description revenue fell 4% sequentially to $78.7 million due to Middle East and Russia-Ukraine disruptions; Production Enhancement climbed 15% to $45.9 million.
Q3 guidance calls for revenue of $128.5 million-$135.5 million and EPS of $0.12-$0.20.
